MYRIAD GENETICS INC — Director's Dealing 2018

Jun 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-05-30

Reporting Person: Capone Mark Christopher (President & C.E.O.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-30	Common Stock	M	90000	$22.93	Acquired	422175	Direct
2018-05-30	Common Stock	S	90000	$38.00	Disposed	332175	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-30	Non-Qualified Stock Option (right to buy)	$22.93	M	90000	Disposed	2018-09-10	Common Stock (90000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.